Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,482 across all filing types
Latest filing 2023-12-21 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for Buy-back of treasury shares
Regulatory Filings Classification · 99% confidence The document is titled 'Current report №250/2023' and explicitly states the company's intention to 'buy back treasury shares'. It details the number of shares (20,000), the price (BGN 5.72), and the purchase date (22 December 2023). This action directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The filing type code for this is POS.
2023-12-21 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
Director's Dealing Classification · 100% confidence The document details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD) regarding the sale of financial instruments (Warrants). This structure, focusing on insider transactions by management, directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by company directors and executives.
2023-12-21 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD). It specifies the nature of the transaction ('Buy'), the instrument ('Shares'), the price (5.80), and the volume (2,000). This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by company directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-12-21 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
Director's Dealing Classification · 100% confidence The document text details a transaction report concerning an individual, Ognian Donev, who is an Executive director and chairman of the Board of directors of Sopharma AD (the issuer). Section 4 explicitly details the 'Nature of the transaction' as 'Sell' and lists the 'Price(s) and volume(s)' of shares traded. This structure is characteristic of mandatory regulatory filings reporting insider transactions, specifically director's dealings, as mandated by regulations like MAR (Regulation (EU) No 596/2014 mentioned in the text). This directly corresponds to the definition of Director's Dealing (DIRS).
2023-12-21 English
Notification for buy-back of treasury sahres
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated 21.12.2023 concerning 'Treasury shares'. It explicitly states that the Company 'bought 30 000 (thirty thousand) own shares' and details the total number of treasury shares held afterward. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2023-12-21 English
Notification for buy-back treasury shares
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a 'Current report' dated December 20, 2023, explicitly stating the company's intention to 'buy back treasury shares'. It details the number of shares (20,000), the price (BGN 5.82), and the purchase date (21 December 2023). This action directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The filing code for this activity is POS.
2023-12-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.